BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

WinterLight Labs (acquired by Cambridge Cognition)

WinterLight Labs logo

Website
http://winterlightlabs.com/
Founded
2015

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

We want to improve the lives of people with dementia and psychiatric illness. To do this, we’re building better, more sensitive tools that will allow us to track, screen for and predict the onset of these diseases more accurately.
Winterlight Labs was founded in 2015 in Toronto, Canada by Frank Rudzicz, Katie Fraser, Liam Kaufman and Maria Yancheva. Our team of experts specializes in computational linguistics, cognitive neuroscience, and machine learning. We have developed a proprietary, tablet-based technology that assesses cognitive health (including memory, thinking, and reasoning) by analysing hundreds of language markers from short snippets of speech.

speech processing

R&D Platform

Assess and monitor cognitive health by analyzing a short speech sample. Allows researchers to: Identify patients, screen patients, and evaluate response to therapy for clinical trials of mental health treatments.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.